Neurizon inks $1.5M loan against R&D Tax Rebate
Neurizon Therapeutics (ASX:NUZ) retreated in intra-day trade on Wednesday after inking a non-dilutive loan agreement for $1.5 million to fund its current and future operations seeking to treat Huntington’s with its flagship drug NUZ-001.The funds in question are secured against it...
Currently unlisted.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
AAG | Ann: Removal from official list | 06/05/11 | 4 | 5.3K | |||
|
|||||||
AAG | Ann: Quarterly Activities and Cashflow Reports | 29/04/11 | 0 | 1.1K | |||
|
|||||||
AAG +WGR | Ann: Change in substantial holding from WGR | 29/04/11 | 0 | 862 | |||
|
|||||||
AAG | Ann: Suspension from Official Quotation | 28/04/11 | 0 | 878 | |||
|
|||||||
AAG +WGR | Ann: Closure of Off Market Takeover for Aragon | 28/04/11 | 0 | 857 | |||
|
|||||||
AAG +WGR | Ann: WGR: Compulsory Acquisition | 28/04/11 | 1 | 1.4K | |||
|
|||||||
AAG | Ann: Change of Director's Interest Notice | 27/04/11 | 0 | 580 | |||
|
|||||||
AAG +WGR | Ann: Change in substantial holding from WGR | 27/04/11 | 0 | 620 | |||
|
See All Discussions